Profile picture

Doctor Yury Mareev

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
Membership: HFA Member
Follow
Biography
Yura Mareev currently works at the National Medical Research Center for Preventive Medicine (Moscow) and Robertson Centre for Biostatistics, University of Glasgow (Glasgow). Yura does research in Cardiology.
Logo ESC

Contributor content

Iron deficiency in heart failure: comparison of esc criteria with alternative definitions
Presentation
Iron deficiency in heart failure: comparison of esc criteria with alternative definitions
Is atrial fibrillation an independent predictor of mortality in patients with heart failure and a reduced left ventricular ejection fraction?
Presentation
Is atrial fibrillation an independent predictor of mortality in patients with heart failure and a reduced left ventricular ejection fraction?
The long-term prognosis of patients with different types of heart failure admitted with decompensation in Russia
Presentation
The long-term prognosis of patients with different types of heart failure admitted with decompensation in Russia
Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET
Presentation
Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET
Do patients with midterm HF have profile like HFrEF or HFpEF or they have their individual profile. Data from Russian national register 2012
Presentation
Do patients with midterm HF have profile like HFrEF or HFpEF or they have their individual profile. Data from Russian national register 2012
Why don't beta-blockers work in patients with heart failure and atrial fibrillation? Pauses?
Presentation
Why don't beta-blockers work in patients with heart failure and atrial fibrillation? Pauses?
New clinical assessment scale - useful tool to analysis effect of treatment and prognosis of patients with heart failure
Presentation
New clinical assessment scale - useful tool to analysis effect of treatment and prognosis of patients with heart failure
Mortality and rehospitalization data from diuretic therapy with effective doses of oral torasemide and furosemide in treatment of patients with exacerbation of chronic heart failure (DUEL-CHF) trial
Presentation
Mortality and rehospitalization data from diuretic therapy with effective doses of oral torasemide and furosemide in treatment of patients with exacerbation of chronic heart failure (DUEL-CHF) trial

ESC 365 is supported by